1-2 of 2
David G. Huntsman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Histone Deacetylase Inhibitors Synergize with Catalytic Inhibitors of EZH2 to Exhibit Antitumor Activity in Small Cell Carcinoma of the Ovary, Hypercalcemic Type

Yemin Wang, Shary Yuting Chen, Shane Colborne, Galen Lambert, Chae Young Shin, Nancy Dos Santos, Krystal A. Orlando, Jessica D. Lang, William P.D. Hendricks, Marcel B. Bally, Anthony N. Karnezis, Ralf Hass, T. Michael Underhill, Gregg B. Morin, Jeffrey M. Trent, Bernard E. Weissman, David G. Huntsman
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2018) 17 (12): 2767–2779.
https://doi.org/10.1158/1535-7163.MCT-18-0348
Published: 03 December 2018
View article titled, Histone Deacetylase Inhibitors Synergize with Catalytic Inhibitors of EZH2 to Exhibit Antitumor Activity in Small Cell Carcinoma of the Ovary, Hypercalcemic Type
Open the PDF for Histone Deacetylase Inhibitors Synergize with Catalytic Inhibitors of EZH2 to Exhibit Antitumor Activity in Small Cell Carcinoma of the Ovary, Hypercalcemic Type in another window
Includes: Supplementary data
Journal Articles

Enhanced GAB2 Expression Is Associated with Improved Survival in High-Grade Serous Ovarian Cancer and Sensitivity to PI3K Inhibition

Sally J. Davis, Karen E. Sheppard, Michael S. Anglesio, Joshy George, Nadia Traficante, Sian Fereday, Maria P. Intermaggio, Usha Menon, Aleksandra Gentry-Maharaj, Jan Lubinski, Jacek Gronwald, Celeste Leigh Pearce, Malcolm C. Pike, Anna Wu, Stefan Kommoss, Jacobus Pfisterer, Andreas du Bois, Felix Hilpert, Susan J. Ramus, David D.L. Bowtell, David G. Huntsman, Richard B. Pearson, Kaylene J. Simpson, Ian G. Campbell, Kylie L. Gorringe
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (6): 1495–1503.
https://doi.org/10.1158/1535-7163.MCT-15-0039
Published: 04 June 2015
View article titled, Enhanced <em>GAB2</em> Expression Is Associated with Improved Survival in High-Grade Serous Ovarian Cancer and Sensitivity to PI3K Inhibition
Open the PDF for Enhanced <em>GAB2</em> Expression Is Associated with Improved Survival in High-Grade Serous Ovarian Cancer and Sensitivity to PI3K Inhibition in another window
Includes: Supplementary data